An antigen-specific immunotherapeutic, AKS-107, deletes insulin-specific B cells and prevents murine autoimmune diabetes by Alleva, David G, Delpero, Andrea R, Sathiyaseelan, Thillainaygam, Murikipudi, Sylaja, Lancaster, Thomas M, Atkinson, Mark A, Wasserfall, Clive H, Yu, Liping, Ragupathy, Ramya, Bonami, Rachel H, Zion, Todd C

Get full text

Immunogenicity phase II study evaluating booster capacity of nonadjuvanted AKS-452 SARS-Cov-2 RBD Fc vaccine by Alleva, David G., Feitsma, Eline A., Janssen, Yester F., Boersma, Hendrikus H., Lancaster, Thomas M., Sathiyaseelan, Thillainaygam, Murikipudi, Sylaja, Delpero, Andrea R., Scully, Melanie M., Ragupathy, Ramya, Kotha, Sravya, Haworth, Jeffrey R., Shah, Nishit J., Rao, Vidhya, Nagre, Shashikant, Ronca, Shannon E., Green, Freedom M., Shaw, Stephen A., Aminetzah, Ari, Kruijff, Schelto, Brom, Maarten, van Dam, Gooitzen M., Zion, Todd C.

Get full text

Development of an IgG-Fc fusion COVID-19 subunit vaccine, AKS-452 by Alleva, David G., Delpero, Andrea R., Scully, Melanie M., Murikipudi, Sylaja, Ragupathy, Ramya, Greaves, Emma K., Sathiyaseelan, Thillainaygam, Haworth, Jeffrey R., Shah, Nishit J., Rao, Vidhya, Nagre, Shashikant, Lancaster, Thomas M., Webb, Sarah S., Jasa, Allison I., Ronca, Shannon E., Green, Freedom M., Elyard, Hanne Andersen, Yee, JoAnn, Klein, Jeffrey, Karnes, Larry, Sollie, Frans, Zion, Todd C.

Get full text

A randomized phase I/II safety and immunogenicity study of the Montanide-adjuvanted SARS-CoV-2 spike protein-RBD-Fc vaccine, AKS-452 by Feitsma, Eline A., Janssen, Yester F., Boersma, Hendrikus H., van Sleen, Yannick, van Baarle, Debbie, Alleva, David G., Lancaster, Thomas M., Sathiyaseelan, Thillainaygam, Murikipudi, Sylaja, Delpero, Andrea R., Scully, Melanie M., Ragupathy, Ramya, Kotha, Sravya, Haworth, Jeffrey R., Shah, Nishit J., Rao, Vidhya, Nagre, Shashikant, Ronca, Shannon E., Green, Freedom M., Aminetzah, Ari, Sollie, Frans, Kruijff, Schelto, Brom, Maarten, van Dam, Gooitzen M., Zion, Todd C.

Get full text

Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19 subunit vaccine, AKS-452 by Janssen, Yester F., Feitsma, Eline A., Boersma, Hendrikus H., Alleva, David G., Lancaster, Thomas M., Sathiyaseelan, Thillainaygam, Murikipudi, Sylaja, Delpero, Andrea R., Scully, Melanie M., Ragupathy, Ramya, Kotha, Sravya, Haworth, Jeffrey R., Shah, Nishit J., Rao, Vidhya, Nagre, Shashikant, Ronca, Shannon E., Green, Freedom M., Aminetzah, Ari, Sollie, Frans, Kruijff, Schelto, Brom, Maarten, van Dam, Gooitzen M., Zion, Todd C.

Get full text

Abstract P4-02-01: Targeting insulin receptor in estrogen receptor positive breast cancer by Cao, Jingran, Fettig, Lynsey M., LaPara, Kelly, Zhang, Xihong, Murikipudi, Sylaja, Delpero, Andrea R., Lancaster, Thomas M., Zion, Todd C., Yee, Douglas

Get full text

Abstract P1-21-05: A novel long-acting insulin for cancer therapy reduces xenograft tumor growth by Fettig, Lynsey M, Zhang, Xihong, LaPara, Kelly, Murikipudi, Sylaja, Delpero, Andrea R, Lancaster, Thomas M, Zion, Todd C, Yee, Douglas

Get full text

Hydrologic refugia, plants, and climate change by McLaughlin, Blair C., Ackerly, David D., Klos, P. Zion, Natali, Jennifer, Dawson, Todd E., Thompson, Sally E.

Get full text